{
  "meta": {
    "title": "38_The_Pancreas",
    "url": "https://brainandscalpel.vercel.app/38-the-pancreas-8f100bef.html",
    "scrapedAt": "2025-11-30T12:35:08.049Z"
  },
  "questions": [
    {
      "text": "Which scientists were awarded the Nobel Prize for the discovery of insulin?",
      "choices": [
        {
          "id": 1,
          "text": "Banting and Best"
        },
        {
          "id": 2,
          "text": "Sanger"
        },
        {
          "id": 3,
          "text": "Banting and McLeod"
        },
        {
          "id": 4,
          "text": "Collip and McLeod"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Banting</strong> and <strong>McLeod</strong> were awarded the Nobel Prize for the discovery of insulin.</p>\n<p>In 1921, Banting took his idea to Professor John Macleod at the University of Toronto, who was a leading figure in the study of diabetes in Canada. Macleod gave Banting a laboratory with a minimum equipments and ten dogs. Banting also got an assistant, a medical student by the name of Charles Best. &nbsp;</p>\n<p>In 1923, the Nobel Committee decided to award Banting and Macleod the Nobel Prize in Physiology or Medicine. The decision of the Nobel Committee made Banting furious. He felt that the prize should have been shared between him and Best.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0809",
      "difficulty": "medium"
    },
    {
      "text": "For cells of islets of Langerhans, which of the following is correctly matched?",
      "choices": [
        {
          "id": 1,
          "text": "Β –somatostatin"
        },
        {
          "id": 2,
          "text": "D- glucagon"
        },
        {
          "id": 3,
          "text": "F- pancreatic polypeptide"
        },
        {
          "id": 4,
          "text": "A – insulin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correctly matched pair is<strong> F-Pancreatic polypeptide</strong>.&nbsp;</p>\n<p>Cells of the endocrine pancreas are divided into:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Cell type</strong></p>\n</td>\n<td>\n<p><strong>What they secrete</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>A (alpha)</strong></p>\n</td>\n<td>\n<p>Glucagon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>B (beta)</strong></p>\n</td>\n<td>\n<p>Insulin and amylin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>D (delta)</strong></p>\n</td>\n<td>\n<p>Somatostatin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>F or PP</strong></p>\n</td>\n<td>\n<p>Pancreatic polypeptide</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The close interrelations among these cells allow direct control of secretion of some of the hormones by the other hormones. For example:</p>\n<ul>\n<li>Insulin inhibits glucagon secretion,</li>\n<li>Amylin inhibits glucagon secretion, and</li>\n<li>Somatostatin inhibits secretion of insulin and glucagon.&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6239",
      "difficulty": "easy"
    },
    {
      "text": "A 21-year-old female is found in a semiconscious state. On initial evaluation, her CBG is 23mg/dL. Her parents tell that the patient is an athlete and was trying to gain weight recently. An evaluation of which of the following will help in establishing a diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Pancreatic polypeptide"
        },
        {
          "id": 2,
          "text": "Glucagon"
        },
        {
          "id": 3,
          "text": "Somatostain"
        },
        {
          "id": 4,
          "text": "C peptide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical vignette strongly suggests hypoglycemia due to&nbsp;surreptitious use of <strong>exogenous insulin</strong>, characterized by a <strong>low C-peptide level.</strong></p>\n<p><strong>Insulin abuse</strong> is a method for <strong>increasing muscle bulk</strong> and <strong>performance enhancement</strong> in athletes, although less common than anabolic steroid abuse. <strong>Exogenous insulin</strong> does not contain C-peptide. Therefore blood level of <strong>C-peptide</strong> will be<strong> low</strong> in such patients. On the other hand, <strong>endogenous</strong> production of insulin will be characterized by <strong>high C-peptide</strong> level in blood.</p>\n<div class=\"page\" title=\"Page 939\">&nbsp;</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2119e165009f4a7d8fa86f6642290706x1280x1166.JPEG\" alt=\"Explanation Image\"><p>Insulin is composed of two chains A and B, and a connecting peptide called C peptide. The insulin and C peptide are packaged in the <strong>secretory granules</strong> and secreted in <strong>equimolar amounts</strong>.&nbsp;</p>\n<p>Importance of C-peptide:</p>\n<div class=\"page\" title=\"Page 939\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>C peptide is measured by <strong>radioimmunoassay</strong>, and its level in the blood provides an index of beta-cell function in patients receiving exogenous insulin.&nbsp;If they are unable to produce insulin, they have greatly decreased levels of C peptide.</li>\n<li>C peptide levels can be used to differentiate between an insulinoma (high C-peptide) and exogenous insulin overdose (low C-peptide) in a patient with hypoglycemia.&nbsp;</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6240",
      "difficulty": "easy"
    },
    {
      "text": "The half-life of insulin is ______ minutes?",
      "choices": [
        {
          "id": 1,
          "text": "1-2"
        },
        {
          "id": 2,
          "text": "4-6"
        },
        {
          "id": 3,
          "text": "10-12"
        },
        {
          "id": 4,
          "text": "12-16"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The half-life of <strong>insulin</strong> is <strong>4-6 minutes.&nbsp;</strong></p>\n<p>Insulin is degraded by the<strong> insulinase</strong> enzyme in the <strong>liver</strong>, and to a lesser extent, in the kidneys and muscles.&nbsp;</p>\n<p>Note: Half-life of <strong>C-peptide</strong> is <strong>20-30 minutes</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6260",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old diabetic man is initiated on a new hypoglycemic drug whose mechanism of action is extremely similar to the glucose-mediated insulin release mechanism. Which of the following best represents its mode of action?",
      "choices": [
        {
          "id": 1,
          "text": "Closes ATP sensitive K+ channels"
        },
        {
          "id": 2,
          "text": "Increases cAMP level in cell"
        },
        {
          "id": 3,
          "text": "Participates in carrier mediated transport"
        },
        {
          "id": 4,
          "text": "Causes receptor phosphorylation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Glucose-mediated insulin release occurs through the <strong>closure</strong> of&nbsp;<strong>ATP sensitive K+ channels</strong>. Therefore the new drug being initiated is most probably a <strong>sulfonylurea </strong>which&nbsp;acts via a similar mechanism.</p>\n<p>Increased blood glucose concentration is the primary controller of insulin secretion.&nbsp;Inside the<strong> beta cells</strong>, <strong>glucose</strong> is converted to <strong>glucose-6-phosphate</strong> and later <strong>ATP</strong> is generated. This ATP <strong>closes</strong> ATP sensitive <strong>potassium channels</strong>, leading to a rise in K+ and <strong>depolarization</strong>. This in turn causes the <strong>opening</strong> of <strong>voltage-gated Ca 2+ channels</strong> and influx of Ca+. This ultimately leads to the secretion of insulin via <strong>exocytosis</strong>.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8b3b2a05626e43a3b5317c85e2f28c37x1280x1768.JPEG\" alt=\"Explanation Image\"><p><strong>Diazoxide</strong> keeps the ATP sensitive <strong>K+ channels</strong> <strong>open</strong> and <strong>prevents</strong> depolarization, resulting in a decreased&nbsp;<strong>insulin release</strong>. It is used in patients with insulinoma.</p>\n<p><strong>Sulfonylureas</strong> cause <strong>closure</strong> of the ATP sensitive <strong>K+ channels</strong>, leading to <strong>increased insulin</strong> secretion. It is used in patients with diabetes mellitus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6241",
      "difficulty": "easy"
    },
    {
      "text": "Insulin mainly facilitates glucose uptake in which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Brain"
        },
        {
          "id": 2,
          "text": "Skeletal muscle"
        },
        {
          "id": 3,
          "text": "RBC"
        },
        {
          "id": 4,
          "text": "Kidney"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Insulin mainly&nbsp;</strong>stimulates glucose uptake<strong> by skeletal muscles.</strong></p>\n<p>Glucose uptake by skeletal muscle, cardiac muscle and adipose tissues is via <strong>GLUT-4</strong> which is <strong>insulin-dependent</strong>. In the presence of insulin, GLUT-4 receptors translocate to the cell membrane and hence, glucose uptake by the cell occurs.&nbsp;</p>\n<div class=\"page\" title=\"Page 437\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Most of the <strong>other GLUT</strong> transporters are <strong>not insulin sensitive</strong> and are constitutively expressed in the cell membrane. Ex: GLUT-1 in RBCs, brain and kidneys. (GLUT-3 is also present in the brain and kidneys)</p>\n</div>\n</div>\n</div>\n</div>\n<p>Note: Insulin promotes glucose uptake in the liver. However, this is done by <strong>increasing</strong> the activity of <strong>glucokinase</strong> and <strong>inactivating glycogen phosphorylase</strong>. The net effect is the synthesis of glycogen and decreased breakdown of glycogen.&nbsp;</p><hr><h3>Related Pearl: Glucose Transporters</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n<td>\n<p><strong>Major sites of expression</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secondary active transport</strong></p>\n<p><strong>(Na </strong><strong><sup>+</sup></strong> <strong>-glucose cotransport)</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>SGLT 1</p>\n</td>\n<td>\n<p>Absorption of glucose</p>\n</td>\n<td>\n<p>Small intestine, renal tubules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>SGLT 2</p>\n</td>\n<td>\n<p>Absorption of glucose</p>\n</td>\n<td>\n<p>Renal tubules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Facilitated diffusion</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 1</p>\n</td>\n<td>\n<p>Basal glucose uptake</p>\n</td>\n<td>\n<p>Placenta, blood-brain barrier, brain, red cells, kidneys, colon, many other organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 2</p>\n</td>\n<td>\n<p>&beta;-cell glucose sensor; transport out of intestinal and renal epithelial cells</p>\n</td>\n<td>\n<p>&beta; cells of islets, liver, epithelial cells of small intestine, kidneys</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 3</p>\n</td>\n<td>\n<p>Basal glucose uptake</p>\n</td>\n<td>\n<p>Brain, placenta, kidneys, many other organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 4</p>\n</td>\n<td>\n<p>Insulin-stimulated glucose uptake</p>\n</td>\n<td>\n<p>Skeletal and cardiac muscle, adipose tissue, other tissues</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 5</p>\n</td>\n<td>\n<p>Fructose transport</p>\n</td>\n<td>\n<p>Jejunum, sperm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 6</p>\n</td>\n<td>Function not known</td>\n<td>Brain, spleen, leucocytes</td>\n</tr>\n<tr>\n<td>GLUT 7</td>\n<td>Glucose-6-phosphate transporter in the endoplasmic reticulum</td>\n<td>Liver</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6243",
      "difficulty": "easy"
    },
    {
      "text": "Insulin acts on glucose metabolism by______",
      "choices": [
        {
          "id": 1,
          "text": "↑ facilitated diffusion of glucose"
        },
        {
          "id": 2,
          "text": "↓ permeability of glucose across cell membrane"
        },
        {
          "id": 3,
          "text": "↑ reabsorption of glucose from renal tubules"
        },
        {
          "id": 4,
          "text": "↑ glucose reabsorption from intestine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Insulin stimulates the glucose entry into the cells via <strong>facilitated diffusion</strong> by increasing the number of glucose transporters (GLUTs) in the cell membrane.</p>\n<p>This type of insulin-dependent glucose transport via GLUT 4 is observed in <strong>skeletal muscle, cardiac muscle, </strong>and<strong> adipose tissues.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6245",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old diabetic man develops a gradually increasing demand for exogenous subcutaneous insulin therapy for glycemic control. His current insulin requirement is 130 IU/day. Downregulation of which of the following is associated with his condition?",
      "choices": [
        {
          "id": 1,
          "text": "GLUT 1"
        },
        {
          "id": 2,
          "text": "GLUT 2"
        },
        {
          "id": 3,
          "text": "GLUT 3"
        },
        {
          "id": 4,
          "text": "GLUT 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical vignette is suggestive of<strong> insulin resistance</strong>, which is characterized by the <strong>downregulation</strong> of<strong> GLUT-4</strong>.</p>\n<p><strong>GLUT-4</strong> is an <strong>insulin-dependent</strong> GLUT. Other GLUTs are not insulin sensitive and are constitutively expressed in the cell membrane.&nbsp;</p>\n<p>An arbitrary but clinically useful benchmark considers patients insulin resistant if they require greater than 1 unit/kilogram/day of exogenous insulin to maintain glycemic control. Patients requiring greater than 200 units of&nbsp;exogenous insulin per day are considered severely insulin resistant.&nbsp;</p><hr><h3>Related Pearl: Glucose Transporters</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n<td>\n<p><strong>Major sites of expression</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secondary active transport</strong></p>\n<p><strong>(Na </strong><strong><sup>+</sup></strong> <strong>-glucose cotransport)</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>SGLT 1</p>\n</td>\n<td>\n<p>Absorption of glucose</p>\n</td>\n<td>\n<p>Small intestine, renal tubules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>SGLT 2</p>\n</td>\n<td>\n<p>Absorption of glucose</p>\n</td>\n<td>\n<p>Renal tubules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Facilitated diffusion</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 1</p>\n</td>\n<td>\n<p>Basal glucose uptake</p>\n</td>\n<td>\n<p>Placenta, blood-brain barrier, brain, red cells, kidneys, colon, many other organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 2</p>\n</td>\n<td>\n<p>&beta;-cell glucose sensor; transport out of intestinal and renal epithelial cells</p>\n</td>\n<td>\n<p>&beta; cells of islets, liver, epithelial cells of small intestine, kidneys</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 3</p>\n</td>\n<td>\n<p>Basal glucose uptake</p>\n</td>\n<td>\n<p>Brain, placenta, kidneys, many other organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 4</p>\n</td>\n<td>\n<p>Insulin-stimulated glucose uptake</p>\n</td>\n<td>\n<p>Skeletal and cardiac muscle, adipose tissue, other tissues</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 5</p>\n</td>\n<td>\n<p>Fructose transport</p>\n</td>\n<td>\n<p>Jejunum, sperm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 6</p>\n</td>\n<td>Function not known</td>\n<td>Brain, spleen, leucocytes</td>\n</tr>\n<tr>\n<td>GLUT 7</td>\n<td>Glucose-6-phosphate transporter in the endoplasmic reticulum</td>\n<td>Liver</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6246",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old man presented with diabetic ketoacidosis. After the initial evaluation, he is started on intravenous insulin therapy via an infusion pump. He is at increased risk of developing which of the following electrolyte abnormalities?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperkalemia"
        },
        {
          "id": 2,
          "text": "Hypokalemia"
        },
        {
          "id": 3,
          "text": "Hypernatremia"
        },
        {
          "id": 4,
          "text": "Hyponatermia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In patients who require intravenous insulin therapy, a&nbsp;<strong>rapid</strong> insulin infusion results in <strong>hypokalemia</strong>.&nbsp;</p>\n<p>Therefore such patients should undergo serum electrolyte level assessment at frequent intervals while on insulin infusion for prompt diagnosis and early correction of hypokalemia.</p>\n<p>Insulin <strong>increases</strong> the activity of <strong>Na-K ATPase</strong> in cell membranes so that more <strong>K<sup>+</sup></strong> is <strong>pumped into cells</strong>. Hence, <strong>serum K+ falls</strong>.&nbsp;</p>\n<p>Note: Since insulin decreases serum potassium level, insulin-glucose infusions are used to treat hyperkalemia.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6248",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following increases insulin secretion?",
      "choices": [
        {
          "id": 1,
          "text": "Arginine"
        },
        {
          "id": 2,
          "text": "Propranolol"
        },
        {
          "id": 3,
          "text": "Epinephrine"
        },
        {
          "id": 4,
          "text": "K+ depletion"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Arginine</strong> increases insulin secretion.</p>\n<p>Option B:&nbsp;<strong>&beta;-adrenergic blockers</strong> like propranolol <strong>inhibits</strong> insulin secretion.</p>\n<p>Option C: Epinephrine both stimulates (by beta-adrenergic agonistic action) and inhibits (by alpha-adrenergic agonistic action) the secretion of insulin. However, the<strong> inhibitory effect</strong> of epinephrine is <strong>more dominant</strong> than the stimulatory effect.</p>\n<p>Option D:<strong> Insulin</strong> promotes glucose uptake by cells, <strong>causing reduced</strong> serum <strong>K+</strong>. Low serum K+ does&nbsp;not cause an&nbsp;increase in insulin secretion.&nbsp;</p><hr><h3>Related Pearl: Factors affecting insulin secretion</h3><table>\n<tbody>\n<tr>\n<td><strong>Stimulators</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<p>Glucose</p>\n<p>Mannose</p>\n</td>\n<td>\n<p>2-Deoxyglucose</p>\n<p>Mannoheptulose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucagon</p>\n</td>\n<td>Somatostatin&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Amino acids - leucine arginine</p>\n<p>Intestinal hormones - GIP, GLP-1, gastrin, secretin, CCK</p>\n</td>\n<td>K<sup>+</sup> depletion&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>&nbsp;</p>\n<p>Leptin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acetylcholine (Parasympathetic stimulation )</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>&beta;-adrenergic stimulators</p>\n<p>Theophylline</p>\n<p>Sulfonylureas</p>\n</td>\n<td>\n<p>&alpha;-adrenergic stimulators (norepinephrine, epinephrine)&beta;-Adrenergic blockers&nbsp; (propranolol)</p>\n<p>Diazoxide</p>\n<p>Thiazide diuretics</p>\n<p>Phenytoin&nbsp;</p>\n<p>Alloxan</p>\n<p>Microtubule inhibitors ( Taxanes, Vinca alkaloids)</p>\n<p>Insulin</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6249",
      "difficulty": "medium"
    },
    {
      "text": "Sympathetic stimulation has the following effect on insulin secretion______",
      "choices": [
        {
          "id": 1,
          "text": "Inhibition"
        },
        {
          "id": 2,
          "text": "Stimulation"
        },
        {
          "id": 3,
          "text": "Inhibition followed by stimulation"
        },
        {
          "id": 4,
          "text": "No effect"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 454\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Sympathetic</strong> stimulation <strong>inhibits </strong>insulin secretion. </p>\n<p>The regulation of insulin secretion can be controlled by alpha-adrenergic mediated response and beta-adrenergic mediated response. The stimulation of <strong>alpha-adrenergic </strong>receptor (<strong>α2</strong>) plays an <strong>inhibitory</strong> role in insulin secretion. On the other hand, the stimulation of <strong>beta-adrenergic</strong> receptor (<strong>β2</strong>) plays a <strong>stimulatory</strong> role in insulin secretion.</p>\n<div class=\"page\" title=\"Page 445\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Stimulation of the <strong>sympathetic</strong> nerves to the pancreas releases <strong>norepinephrine</strong> which predominantly acts on <strong>α2-adrenergic receptors, </strong>causing a decrease in insulin secretion.</p>\n<p>Note: If <strong>α-</strong>adrenergic receptors are <strong>blocked</strong>, stimulation of the <strong>sympathetic</strong> nerves causes <strong>increased insulin</strong> secretion mediated by <strong>β2-</strong>adrenergic receptors. </p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Factors affecting insulin secretion</h3><table>\n<tbody>\n<tr>\n<td><strong>Stimulators</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<p>Glucose</p>\n<p>Mannose</p>\n</td>\n<td>\n<p>2-Deoxyglucose</p>\n<p>Mannoheptulose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucagon</p>\n</td>\n<td>Somatostatin&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Amino acids - leucine arginine</p>\n<p>Intestinal hormones - GIP, GLP-1, gastrin, secretin, CCK</p>\n</td>\n<td>K<sup>+</sup> depletion&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>&nbsp;</p>\n<p>Leptin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acetylcholine (Parasympathetic stimulation )</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>&beta;-adrenergic stimulators</p>\n<p>Theophylline</p>\n<p>Sulfonylureas</p>\n</td>\n<td>\n<p>&alpha;-adrenergic stimulators (norepinephrine, epinephrine)&beta;-Adrenergic blockers&nbsp; (propranolol)</p>\n<p>Diazoxide</p>\n<p>Thiazide diuretics</p>\n<p>Phenytoin&nbsp;</p>\n<p>Alloxan</p>\n<p>Microtubule inhibitors ( Taxanes, Vinca alkaloids)</p>\n<p>Insulin</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6255",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following decreases the secretion of both insulin and glucagon?",
      "choices": [
        {
          "id": 1,
          "text": "Epinephrine"
        },
        {
          "id": 2,
          "text": "Somatostatin"
        },
        {
          "id": 3,
          "text": "↑ blood glucose"
        },
        {
          "id": 4,
          "text": "None"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Somatostatin inhibits insulin and glucagon secretion.&nbsp;</p>\n<p>Note: Other actions of somatostatin:</p>\n<ul>\n<li>Inhibits growth hormone secretion. Somatostatin is also known as growth hormone inhibitory hormone (GHIH).</li>\n<li>Decreases motility of the stomach, duodenum, and gallbladder.</li>\n<li>Decreases both secretion and absorption in the gastrointestinal tract.&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6263",
      "difficulty": "easy"
    },
    {
      "text": "Insulin secretion is normally stimulated by_____",
      "choices": [
        {
          "id": 1,
          "text": "GLP 1"
        },
        {
          "id": 2,
          "text": "GLP 2"
        },
        {
          "id": 3,
          "text": "VIP"
        },
        {
          "id": 4,
          "text": "Adrenergic receptor"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Insulin secretion is normally stimulated by <strong>GLP-1</strong>.</p>\n<div class=\"page\" title=\"Page 946\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Glucagon-like peptide&ndash;1</strong> (GLP-1) and <strong>glucose-dependent insulinotropic peptide</strong> (GIP) are called <strong>incretins</strong>&nbsp;and are potent <strong>stimulators</strong> of <strong>insulin secretion</strong>. They also<strong> inhibit</strong> <strong>glucagon</strong> secretion. They are released in the gastrointestinal tract after a person eats a meal. They then cause an <strong>&ldquo;anticipatory&rdquo; increase</strong> in blood insulin in preparation for the glucose and amino acids to be absorbed from the meal.&nbsp;</p>\n<p>Note: Drugs that mimic the action of incretins are used in the management of diabetes.&nbsp;</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Factors affecting insulin secretion</h3><table>\n<tbody>\n<tr>\n<td><strong>Stimulators</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<p>Glucose</p>\n<p>Mannose</p>\n</td>\n<td>\n<p>2-Deoxyglucose</p>\n<p>Mannoheptulose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucagon</p>\n</td>\n<td>Somatostatin&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Amino acids - leucine arginine</p>\n<p>Intestinal hormones - GIP, GLP-1, gastrin, secretin, CCK</p>\n</td>\n<td>K<sup>+</sup> depletion&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>&nbsp;</p>\n<p>Leptin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acetylcholine (Parasympathetic stimulation )</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>&beta;-adrenergic stimulators</p>\n<p>Theophylline</p>\n<p>Sulfonylureas</p>\n</td>\n<td>\n<p>&alpha;-adrenergic stimulators (norepinephrine, epinephrine)&beta;-Adrenergic blockers&nbsp; (propranolol)</p>\n<p>Diazoxide</p>\n<p>Thiazide diuretics</p>\n<p>Phenytoin&nbsp;</p>\n<p>Alloxan</p>\n<p>Microtubule inhibitors ( Taxanes, Vinca alkaloids)</p>\n<p>Insulin</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6257",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following compounds antagonizes the action of insulin?",
      "choices": [
        {
          "id": 1,
          "text": "Neuropeptide Y"
        },
        {
          "id": 2,
          "text": "Growth Hormone"
        },
        {
          "id": 3,
          "text": "Substance P"
        },
        {
          "id": 4,
          "text": "Vasoactive Intestinal Peptide (VIP)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Growth hormone is a hyperglycemic hormone and antagonizes the effect of insulin.</p>\n<p><strong>Hyperglycemic Hormones</strong></p>\n<ul>\n<li>Glucagon</li>\n<li>Epinephrine</li>\n<li>Cortisol</li>\n<li>Growth hormone</li>\n<li>Thyroid Hormone</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6259",
      "difficulty": "medium"
    },
    {
      "text": "In fetus, the insulin secretion begins by _____(months)",
      "choices": [
        {
          "id": 1,
          "text": "5"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "7"
        },
        {
          "id": 4,
          "text": "9"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In a fetus, the <strong>pancreatic islets</strong> are formed in the <strong>third month</strong> of the fetal life, while&nbsp;<strong>insulin secretion</strong> begins&nbsp;at about <strong>5th month</strong> of fetal life.</p>\n<p>The exocrine pancreas starts functioning after birth.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6251",
      "difficulty": "medium"
    },
    {
      "text": "How many parts are there in insulin receptor?",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An <strong>insulin recepto</strong>r has 4  parts. It is <strong>a tetramer</strong> made up of <strong>two α</strong> and <strong>two β</strong> subunits.</p>\n<p>The <strong>α subunits</strong> are <strong>extracel­lular</strong>, whereas the <strong>β subunits</strong> <strong>penetrate</strong> through the <strong>cell membrane</strong> into the cytoplasm.  The intracel­lular portions of the <strong>β subunits </strong>have<strong> tyrosine kinase </strong>activity.</p>\n<div class=\"page\" title=\"Page 939\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Once <strong>insulin binds</strong> to the <strong>alpha</strong> subunits, the portions of the <strong>beta</strong> subunits protruding into the cell become <strong>autophosphorylated</strong>. Autophosphorylation of the beta subunits, in turn, activates a <strong>local tyrosine kinase</strong>, which causes <strong>phosphorylation</strong> of multiple intracellular enzymes. The net effect is to activate some of these enzymes while inactivating others.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a3e2a65c239420fbe62e4de43bd667fx1280x1109.JPEG\" alt=\"Explanation Image\"><p>Note: IRS: Insulin-receptor substrates, PI3K: Phosphatidylinositol 3-kinase.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6262",
      "difficulty": "medium"
    },
    {
      "text": "Regarding the action of insulin, which of the following is true?",
      "choices": [
        {
          "id": 1,
          "text": "Decreased K+ uptake in adipose tissue"
        },
        {
          "id": 2,
          "text": "Increased protein catabolism in Muscle"
        },
        {
          "id": 3,
          "text": "Activation of hormone sensitive lipase"
        },
        {
          "id": 4,
          "text": "Decreased ketogenesis in liver"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Insulin&nbsp;<strong>decreases ketogenesis&nbsp;</strong>in the liver. In the absence of insulin (Type-1 DM), diabetic ketosis may occur.</p>\n<div class=\"page\" title=\"Page 437\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Effects of insulin on various tissues:</strong></p>\n</div>\n</div>\n</div>\n</div>\n<table>\n<tbody>\n<tr>\n<td><strong>Tissue</strong></td>\n<td><strong>Increases</strong></td>\n<td><strong>Decreases</strong></td>\n</tr>\n<tr>\n<td><strong>Adipose tissue</strong></td>\n<td>Increased glucose entry<br />Increased fatty acid synthesis<br />Increased glycerol phosphate synthesis<br />Increased triglycerides deposition<br />Activation of lipoprotein lipase<br />Increased K+ uptake</td>\n<td>Inhibition of hormone-sensitive lipase</td>\n</tr>\n<tr>\n<td><strong>Muscle</strong></td>\n<td>Increased glucose entry<br />Increased glycogen synthesis<br />Increased amino acid uptake<br />Increased protein synthesis in ribosome<br />Increase ketone uptake<br />Increase K+ uptake</td>\n<td>\n<p>Decrease protein catabolism</p>\n<p>Decrease&nbsp; release of glucogenic amino acids</p>\n</td>\n</tr>\n<tr>\n<td><strong>Liver</strong></td>\n<td>Increased protein synthesis<br />Increased lipid synthesis<br />Increased glycogen synthesis &amp; glycolysis</td>\n<td>\n<p>Decrease ketogenesis</p>\n<p>Decreased glucose output due to decreased gluconeogenesis</p>\n</td>\n</tr>\n<tr>\n<td><strong>General</strong></td>\n<td>Increased cell growth</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0810",
      "difficulty": "medium"
    },
    {
      "text": "On giving a patient insulin, which of the following is expected to occur first?",
      "choices": [
        {
          "id": 1,
          "text": "Increased transport of K+ into adipocytes"
        },
        {
          "id": 2,
          "text": "Stimulation of protein synthesis"
        },
        {
          "id": 3,
          "text": "Activation of glycolysis"
        },
        {
          "id": 4,
          "text": "Increase in mRNA for lipolysis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Increased transport of K+ into adipocytes will occur first on giving an injection of insulin.&nbsp;</p>\n<p>Based on time on onset, actions of insulin are classified as:</p>\n<p><strong>Rapid (seconds):&nbsp;</strong>Increased permeability, leading to:</p>\n<ul>\n<li>Increased transport of glucose, amino acids, and K+ into insulin sensitive cells</li>\n</ul>\n<p><strong>Intermediate (minutes):&nbsp;</strong>Changes in activity levels of intracellular enzymes, leading to:</p>\n<ul>\n<li>Stimulation of protein synthesis</li>\n<li>Inhibition of protein degradation</li>\n<li>Activation of glycolytic enzymes and glycogen synthase</li>\n<li>Inhibition of phosphorylase and gluconeogenic enzymes</li>\n</ul>\n<p><strong>Delayed (hours to days):&nbsp;</strong>Changed rates of transcription of DNA, leading to:&nbsp;</p>\n<ul>\n<li>Increase in mRNAs for lipogenic and other enzymes</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0811",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrectly paired?",
      "choices": [
        {
          "id": 1,
          "text": "Epinephrine: increased glycolysis"
        },
        {
          "id": 2,
          "text": "Insulin: increased protein synthesis"
        },
        {
          "id": 3,
          "text": "Glucagon: increased gluconeogenesis"
        },
        {
          "id": 4,
          "text": "Thyroxine: decrease blood glucose"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The incorrect pair is thyroxine - decreased blood glucose.&nbsp;<strong>Thyroxine</strong> is a <strong>diabetogenic hormone</strong> leading to an increase in blood glucose levels.</p>\n<p><strong> Effects Of Hormones On Carbohydrate Metabolism:&nbsp;</strong>&nbsp;</p>\n<ul>\n<li><strong>Catecholamines</strong>: Activation of glycogen phosphorylase and therefore glycogenolysis occurs. Hepatic glucose output is increased, producing hyperglycemia. &nbsp;</li>\n<li><strong> Glucocorticoids</strong>: Glucocorticoids from the adrenal cortex elevate blood glucose by stimulating gluconeogenesis and inhibiting glucose utilization by the cells. &nbsp;</li>\n<li><strong>Growth Hormone</strong>: The effects of growth hormone are partly direct and partly mediated via IGF-I (Insulin-like Growth Factor-I). The growth hormone mobilizes FFA from adipose tissue, thus favoring ketogenesis. It decreases glucose uptake into some tissues (&ldquo;anti-insulin action&rdquo;), increases hepatic glucose output, and may decrease tissue binding of insulin.</li>\n</ul>\n<p>Note: Infusing catecholamine (Epinephrine) mainly promotes <strong>glycogenolysis</strong> and it is also associated with enhanced rates of aerobic <strong>glycolysis in skeletal muscles during exercise</strong> (resulting in adenosine triphosphate production).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0814",
      "difficulty": "medium"
    },
    {
      "text": "A meal rich in insulin-stimulating amino acids but low in carbohydrates does not cause hypoglycemia because _____",
      "choices": [
        {
          "id": 1,
          "text": "Cortisol in the circulation prevents glucose from entering muscle."
        },
        {
          "id": 2,
          "text": "Glucagon secretion is also stimulated by the meal."
        },
        {
          "id": 3,
          "text": "The amino acids in the meal are promptly converted to glucose."
        },
        {
          "id": 4,
          "text": "Insulin does not bind to insulin receptors if the plasma concentration of amino acids is elevated."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A meal rich in arginine and alanine stimulates both insulin and glucagon secretion. Hence, hypoglycemia does not occur.</p>\n<p>Increased blood&nbsp;<strong>amino acids</strong>&nbsp;stimulate secretion of&nbsp;<strong>glucagon</strong>, which in turn causes the amino acids to get&nbsp;<strong>converted</strong>&nbsp;to glucose. So, the mechanism by which hypoglycemia is prevented after a protien rich meal is secretion of glucagon.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0818",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following would be least likely seen 14 days after a rat is injected with a drug that kills all of its pancreatic β cells?",
      "choices": [
        {
          "id": 1,
          "text": "A rise in the plasma H+ concentration"
        },
        {
          "id": 2,
          "text": "A rise in the plasma amino acid  concentration"
        },
        {
          "id": 3,
          "text": "A fall in the plasma amino acid concentration"
        },
        {
          "id": 4,
          "text": "A rise in plasma osmolality"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A fall is plasma amino acid concentration is least likely to be seen in this case.</p>\n<p>Injury to the beta cells of the pancreas impairs insulin production rendering the rat insulin deficient.&nbsp;Due to<strong> insulin deficiency</strong>, catabolism of proteins increases and<strong>&nbsp;amino acids </strong>in plasma<strong> increase.&nbsp;</strong></p>\n<p>Insulin deficiency <strong>increases blood glucose</strong> levels, which lead to glycosuria and osmotic diuresis with <strong>extracellular dehydration</strong>. &nbsp;There is <strong>increase i</strong>n the <strong>plasma osmolality.</strong> &nbsp;</p>\n<p>Insulin deficiency causes increased utilization of fats, excess production of&nbsp;ketoacids and <strong>metabolic acidosis</strong>. Metabolic acidosis -&nbsp;a<strong> rise </strong>in the <strong>plasma H+</strong>&nbsp;develops.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0815",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an action of insulin?",
      "choices": [
        {
          "id": 1,
          "text": "Activation of liver phosphorylase"
        },
        {
          "id": 2,
          "text": "Decreased activity of glucokinase"
        },
        {
          "id": 3,
          "text": "Decreased activity of glycogen synthase"
        },
        {
          "id": 4,
          "text": "Inhibition of  glucose 6-phosphatase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 941\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Insulin inhibits glucose-6-phosphatase.</p>\n<p>Insulin promotes liver uptake, storage, and the use of glucose. After a meal, insulin causes glucose&nbsp;to be rapidly stored in the liver in the form of glycogen. This occurs by:&nbsp;</p>\n<div class=\"page\" title=\"Page 941\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>Inactivation</strong> of <strong>liver phosphorylase</strong>, which is the principal enzyme that causes liver glycogen to split into glucose.&nbsp;</li>\n<li><strong>Enhanced</strong> uptake of glucose by the liver cells by increasing the activity of the enzyme <strong>glucokinase</strong>&nbsp;which causes phosphorylation of glucose after it enters the liver cells. Once phosphorylated, the glucose is temporarily trapped inside the liver cells because phosphorylated glucose cannot diffuse back through the cell membrane.</li>\n<li><strong>Increased</strong> activity of enzymes that promote glycogen synthesis, like <strong>glycogen synthase</strong>.</li>\n</ul>\n<p>When insulin levels drop (Ex: Fasting), glucose phosphatase gets activated. This causes phosphate to get detached from glucose phosphate, allowing free glucose from the liver cells to re-enter circulation.&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0816",
      "difficulty": "medium"
    },
    {
      "text": "A 30 yr old male presents with recurrent attacks of sweating and dizziness. Further workup reveals hypoglycemia, elevated insulin and C-peptide levels. He is diagnosed with insulinoma and given diazoxide. Which of the following is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Opening of the ATP Sensitive K+ channels"
        },
        {
          "id": 2,
          "text": "Closing of the ATP Sensitive K+ channels"
        },
        {
          "id": 3,
          "text": "Increase in number of GLUT-4 receptors"
        },
        {
          "id": 4,
          "text": "Opening of the voltage sensitive Ca2+ channels"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Diazoxide acts by&nbsp;<strong>opening ATP sensitive K+ channels</strong> and causing a <strong>decrease</strong> in<strong> insulin</strong> secretion.&nbsp;</p>\n<p><strong>Glucose</strong> enters beta cells of the pancreas via <strong>GLUT-2</strong> receptors. Once inside, it is phosphorylated by <strong>glucokinase</strong> (rate-limiting step) to glucose-6-phosphate which is&nbsp;oxidized to form adenosine triphosphate (<strong>ATP</strong>). This ATP causes <strong>closure</strong> of ATP-sensitive <strong>potassium</strong> channels and hence <strong>depolarization</strong>. This leads to <strong>opening</strong> voltage-gated <strong>calcium</strong> channels and Ca2+ influx. This stimulates <strong>fusion</strong> of the insulin-containing vesicles with the cell membrane and <strong>secretion of insulin</strong> into the extracellular fluid by <strong>exocytosis</strong>.&nbsp;</p>\n<p><strong>Diazoxide</strong> keeps the ATP sensitive <strong>K+ channels</strong> <strong>open</strong> and prevents depolarization and subsequent insulin release.&nbsp;</p>\n<p><strong>Sulfonylureas</strong> cause <strong>closure</strong> of the ATP sensitive <strong>K+ channels</strong>, leading to increased insulin secretion.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f34b03dde7034bfa9a0264068500b34bx1280x1768.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0819",
      "difficulty": "medium"
    },
    {
      "text": "Coma occurs at a glucose level below _____.",
      "choices": [
        {
          "id": 1,
          "text": "30 mg/dl"
        },
        {
          "id": 2,
          "text": "45 mg/dl"
        },
        {
          "id": 3,
          "text": "15 mg/dl"
        },
        {
          "id": 4,
          "text": "5 mg/dl"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Coma occurs when glucose levels fall below 30 mg/dL.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2d29bde55b0045a8b7a573f74632e9a2x1021x1405.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0817",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following hormones use receptor tyrosine kinase signalling?",
      "choices": [
        {
          "id": 1,
          "text": "Insulin"
        },
        {
          "id": 2,
          "text": "TSH"
        },
        {
          "id": 3,
          "text": "TRH"
        },
        {
          "id": 4,
          "text": "MSH"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Insulin</strong>&nbsp;uses the <strong>receptor tyrosine kinase signalling</strong> to exert its functions.</p>\n<p>Other hormones acting in a similar fashion includes</p>\n<ul>\n<li>Growth hormone</li>\n<li><strong>Growth</strong> <strong>factors</strong> like VEGF, PDGF, FGF, NGF</li>\n<li>Prolactin</li>\n<li>Leptin</li>\n</ul><hr><h3>Related Pearl: Mechanisms of Action of Hormones</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Types of hormone receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to intracellular receptors</strong></td>\n</tr>\n<tr>\n<td rowspan=\"3\">Cytoplasmic receptors</td>\n<td>Glucocorticoids</td>\n</tr>\n<tr>\n<td>Mineralocorticoids</td>\n</tr>\n<tr>\n<td>Androgens</td>\n</tr>\n<tr>\n<td> </td>\n<td>Vitamin D</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Nuclear receptors</td>\n<td>Thyroid hormones</td>\n</tr>\n<tr>\n<td>Vitamins A</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to cell surface receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">1. <strong>G-protein coupled receptors</strong> (GPCR)</td>\n</tr>\n<tr>\n<td rowspan=\"9\"><strong>Gs</strong>: stimulation of second messenger cAMP</td>\n<td>ACTH, CRH</td>\n</tr>\n<tr>\n<td>TSH, GHRH</td>\n</tr>\n<tr>\n<td>FSH, LH, hCG</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Catecholamines (β receptors)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td>Glucagon</td>\n</tr>\n<tr>\n<td>Secretin</td>\n</tr>\n<tr>\n<td>Parathyroid hormone</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>Gi: </strong>inhibition of second messenger cAMP</td>\n<td>Catecholamines (ɑ<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Acetylcholine (M2, M4)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td rowspan=\"11\">\n<p><strong>Gq</strong>: second messenger is phospholipase C or cGMP</p>\n</td>\n<td><strong>Phospholipase C (IP3 DAG pathway):</strong></td>\n</tr>\n<tr>\n<td>GnRH, GHRH, TRH</td>\n</tr>\n<tr>\n<td>Catecholamines (ɑ<sub>1</sub> receptors)</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>1</sub> receptor)</td>\n</tr>\n<tr>\n<td>Gastrin</td>\n</tr>\n<tr>\n<td>Cholecystokinin</td>\n</tr>\n<tr>\n<td>Oxytocin</td>\n</tr>\n<tr>\n<td>Acetylcholine (M1, M3, M5)</td>\n</tr>\n<tr>\n<td><strong>cGMP:</strong></td>\n</tr>\n<tr>\n<td>Atrial natriuretic peptide</td>\n</tr>\n<tr>\n<td>Nitric oxide</td>\n</tr>\n<tr>\n<td colspan=\"2\">2. <strong>Tyrosine kinase</strong> receptors</td>\n</tr>\n<tr>\n<td rowspan=\"5\">Through the <strong>JAK-STAT</strong> (non-receptor tyrosine kinase) or <strong>MAP kinase</strong> (receptor tyrosine kinase) pathway </td>\n<td>Growth factors like IGF, VEGF, FGF, PDGF</td>\n</tr>\n<tr>\n<td>Growth hormone</td>\n</tr>\n<tr>\n<td>Erythropoietin</td>\n</tr>\n<tr>\n<td>Insulin</td>\n</tr>\n<tr>\n<td>Prolactin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Notes: <br />1. Even though the cytoplasmic receptors are present in the cytoplasm, once the <strong>hormone-receptor complex</strong> is formed it moves to the <strong>nucleus</strong> for its actions.</p>\n<p>2. <strong>Vitamin D</strong> is a <strong>cytoplasmic receptor.</strong> All intracellular receptors are inherently nuclear receptors as they bind and get activated at the nucleus as mentioned above but they have two sites of primary action- cytoplasm and nucleus. </p>\n<p>3. While receptor tyrosine kinases have intrinsic tyrosine kinase activity, non-receptor tyrosine kinases have an external tyrosine kinase component that interacts with the receptor as and when required. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3061",
      "difficulty": "easy"
    }
  ]
}